<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=yes">
    <title>Amphotericin B Dosage</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 20px;
            padding: 20px;
            background-color: #f9f9f9;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            background-color: #fff;
            border-radius: 10px;
            box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.1);
        }

        h1 {
            color: #fcf2f2;
            font-size: 28px;
            font-weight: bold;
            padding: 10px;
            border: 2px solid #afaaaa;
            border-radius: 10px;
            background-color: #2c8ed0;
            text-align: center; /* Center the text */
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            font-size: 16px;
            text-align: center;
        }

        th, td {
            padding: 12px;
            border-bottom: 1px solid #ddd;
        }

        th {
            background-color: #f2f2f2;
        }

        .highlight {
            background-color: #c3e6cb;
        }

        .dose-range {
            color: red;
            font-weight: bold;
        }

        .section-title {
            margin-top: 20px;
            font-size: 18px;
            font-weight: bold;
        }

        .highlight-dose {
            color: #ff5733;
            font-size: 24px;
            font-weight: bold;
            background-color: #fbe9e7;
            padding: 5px 10px;
            border-radius: 5px;
        }

        .button-group {
            display: flex;
            justify-content: center;
            gap: 10px;
            margin-top: 20px;
        }

        .back-button, .back-button-secondary {
            padding: 10px 20px;
            font-size: 16px;
            cursor: pointer;
            text-align: center;
            text-decoration: none;
            outline: none;
            color: #fff;
            border: none;
            border-radius: 10px;
            box-shadow: 0 5px #999;
        }

        .back-button {
            background-color: #f44336;
        }

        .back-button:hover {
            background-color: #d32f2f;
        }

        .back-button-secondary {
            background-color: #008CBA;
        }

        .back-button-secondary:hover {
            background-color: #007B9A;
        }

        footer {
            text-align: center;
            color: #00000035;
            font-size: 14px;
            padding: 10px;
            width: 100%;
        }

        /* Mobile-Specific Adjustments */
        @media (max-width: 600px) {
            body {
                padding: 10px;
            }

            h1 {
                font-size: 20px; /* Reduce font size for mobile */
                padding: 5px; /* Reduce padding */
            }

            .highlight-dose {
                font-size: 20px; /* Adjust font size */
            }

            .section-title {
                font-size: 14px;
            }

            .table-wrapper {
                overflow-x: auto; /* Allow horizontal scrolling */
                margin-bottom: 15px;
            }

            table {
                font-size: 14px; /* Reduce font size */
            }

            th, td {
                padding: 8px; /* Reduce padding for smaller screens */
            }

        }
    </style>
</head>
<body>

    <h1>Amphotericin B Dosage Information</h1>
<!-- Display the calculated PMA and Postnatal Age -->
<p><strong>PMA:</strong> {{ pma_weeks }} weeks and {{ pma_days }} days</p>
<p><strong>Calc.:</strong> {{ calc }} weeks</p>
<p><strong>Postnatal Age:</strong> {{ postnatal_days }} days</p>
<p><strong>Birth Weight (BW):</strong> {{ bw }} kg</p>

<!-- Display the calculated dosage for neonates -->
<div class="section-title">Calculated Dosage for Neonates</div>

<!-- Display the Maintenance Dose (Range) -->
<p><strong>Maintenance Dose:</strong> <span class="highlight-dose">{{ maintenance_dose_min }} to {{ maintenance_dose_max }} mg</span></p>


    <!-- Dose Section -->
    <div class="section-title">Dose</div>
    <p>1 to 1.5 mg/kg every 24 hours IV infusion. Duration of therapy for candidemia, without metastatic complications, is 2 weeks after documented clearance of Candida from the bloodstream and resolution of symptoms. For CNS infection, continue until all signs, symptoms, and CSF and radiological abnormalities have resolved.</p>
    <p>Dosage modification for renal dysfunction is only necessary if serum creatinine increases greater than 0.4 mg/dL from baseline during therapy. Hold dose for 2 to 5 days. Alternate-day dosing is recommended over decreasing daily dose in patients experiencing renal toxicity.</p>

    <!-- Administration Section -->
    <div class="section-title">Administration</div>
    <p>Infuse over 2 to 6 hours at a concentration not to exceed 0.1 mg/mL. Some institutions have used 0.5 mg/mL concentrations in pediatric patients. Avoid rapid administration (hypotension, hypokalemia, arrhythmias, and shock can occur). <strong>Do not flush IV or mix amphotericin with saline solution; precipitation will occur.</strong> In-line filter with pore diameter no less than 1 micron may be used.</p>
    <p>To avoid febrile reactions, administration of acetaminophen or diphenhydramine may be considered. Some suggest starting with 0.25 mg/kg/day, followed by increases of 0.25 mg/kg/day until the target dose is reached. For severe infections, the dose should be initiated at the target dose.</p>

    <!-- Uses Section -->
    <div class="section-title">Uses</div>
    <p>Treatment of systemic fungal infections and severe superficial mycoses.</p>

    <!-- Neonatal Candidiasis Including CNS Infection Section -->
    <div class="section-title">Neonatal Candidiasis, Including CNS Infection</div>
    <ul>
      <p>Invasive candidiasis and candidemia, or very low-birth weight infants with asymptomatic candiduria.</p>
        <li>Amphotericin B deoxycholate is recommended.</li>
        <li>Fluconazole IV or oral is an alternative for those who have not been receiving prophylaxis with fluconazole.</li>
        <li>Lipid formulation amphotericin B is an alternative, but use with caution, especially in the presence of urinary tract involvement.</li>
        <li>Echinocandins (caspofungin, anidulafungin, micafungin) are for salvage therapy or in scenarios of resistance or toxicity to amphotericin B or fluconazole.</li>

      <p>Central nervous system infections</p>
        <li>Amphotericin B deoxycholate is recommended</li>
        <li>Liposomal amphotericin B agent is an alternative.</li>
        <li>Salvage therapy with flucytosine may be added in those patients who have not responded to</li>
        <li>Fluconazole may be used as step-down therapy for those patients with fluconazole-susceptible isolates who respond to initial therapy</li>

      <p>Neonatal intensive care unit (with greater than 10% rate of invasive candidiasis)</p>
        <li>Prophylaxis with IV or oral fluconazole for 6 weeks is recommended for neonates with birth weights of less than 1000 g</li>
        <li>Prophylaxis with oral nystatin is an alternative in neonates with birth weights of less than 1500 g when fluconazole is unavailable or fluconazole resistance is present</li>
    </ul>

    <!-- Adverse Effects Section -->
    <div class="section-title">Adverse Effects</div>
    <p>Hypokalemia (serum K* less than 3 mmol/L) and/or a transient increase in serum creatinine occurs in approximately 16% of treated patients. Renal blood flow and GFR may be decreased by 20% to 60%.
        Injures tubular epithelium with resultant urinary loss of potassium and magnesium, decreased reabsorption of sodium, and renal tubular acidosis. Sodium intake greater than 4 mEqkg per day may prevent or decrease nephrotoxicity. Anemia, thrombocytopenia, hypokalemia, nausea/vomiting, and fever chills. Consider analgesia before beginning infusion. Cardiac arrest has occurred in patients who received 10 times the recommended dose.</p>

    <!-- Black Box Warning Section -->
    <div class="section-title">Black Box Warning</div>
    <p>According to the manufacturer's black box warning, it is recommended that the product name and dosage are verified if the prescribed dose exceeds 1.5 mg/kg. Overdose can result in potentially fatal cardiac or cardiorespiratory arrest.</p>

    <!-- Monitoring Section -->
    <div class="section-title">Monitoring</div>
    <p>Monitor CBC, electrolytes, urine output, BUN, and serum creatinine at least every other day. Observe IV site for irritation. For candidemia, monitor blood cultures daily or every other day until Candida is cleared.</p>

    <!-- Pharmacology Section -->
    <div class="section-title">Pharmacology</div>
    <p>Amphotericin B binds to ergosterol in the membrane of sensitive fungi. The therapeutic concentration range is not well-defined. Elimination half-life is approximately 15 days. Drug may accumulate in tissues and be excreted renally for months.</p>

    <!-- Special Considerations Section -->
    <div class="section-title">Special Considerations/Preparation</div>
    <p>Available as powder for injection in 50-mg vials. Protect from light. Reconstitute with 10 mL of D<sub>5</sub>W or preservative-free sterile water to a concentration of 5 mg/mL, then dilute to no greater than 0.1 mg/mL for infusion.</p>

    <!-- Pharmacology Section -->
    <div class="section-title">Pharmacology</div>
    <p>Amphotericin B binds to ergosterol in the membrane of sensitive fungi and may be fungicidal or fungistatic. The therapeutic concentration range is not well-defined. Highly protein-bound (greater than 90%). Elimination half-life is approximately 15 days. Drug may accumulate in tissues to a significant concentration and be excreted renally for months.</p>

    <!-- Special Considerations/Preparation Section -->
    <div class="section-title">Special Considerations/Preparation</div>
    <p>Available as powder for injection in 50-mg vials. Protect the vials from light. Reconstitute with 10 mL of D<sub>5</sub>W or preservative-free sterile water to a concentration of 5 mg/mL, then dilute further using D<sub>5</sub>W to a concentration no greater than 0.1 mg/mL for infusion. Reconstituted solution stable for 24 hours at room temperature or 7 days in refrigerator. <strong>Do not flush IV or mix amphotericin with saline solution; precipitation will occur.</strong> May filter if necessary; mean pore diameter should not be less than 1 micron. The manufacturer recommends protecting the solution from light during administration. However, there are available data that demonstrate protection from light to be unnecessary in typical hospital lighting if administered within 24 hours of preparation.</p>

    <!-- Intravitreal Injection Section -->
    <div class="section-title">Intravitreal Injection</div>
    <p>Amphotericin B deoxycholate 5 to 10 mcg/0.1 mL of sterile water.</p>

    <!-- Solution Compatibility Section -->
    <div class="section-title">Solution Compatibility</div>
    <p>D<sub>5</sub>W, D<sub>10</sub>W, D<sub>15</sub>W, and D<sub>20</sub>W.</p>

    <!-- Solution Incompatibility Section -->
    <div class="section-title">Solution Incompatibility</div>
    <p>NS (Normal Saline).</p>

    <!-- Terminal Injection Site Compatibility Section -->
    <div class="section-title">Terminal Injection Site Compatibility</div>
    <p>Amiodarone, heparin, hydrocortisone, sodium bicarbonate, and zidovudine.</p>

    <!-- Terminal Injection Site Incompatibility Section -->
    <div class="section-title">Terminal Injection Site Incompatibility</div>
    <p>Fat emulsion. Amikacin, aztreonam, calcium chloride, calcium gluconate, cefepime, cimetidine, ciprofloxacin, dopamine, enalaprilat, fluconazole, gentamicin, linezolid, magnesium sulfate, meropenem, penicillin G, piperacillin/tazobactam, potassium chloride, propofol, ranitidine, remifentanil, and tobramycin.</p>

    <div class="button-group">
        <a href="javascript:history.back()" class="back-button-secondary">Back</a>
        <a href="{{ url_for('index') }}" class="back-button">Back to Home</a>
    </div>

    <footer>
        <p>Developed by Sukhontha Boonsookchan | update {{ update_date }}</p>
    </footer>

</body>
</html>